Activated v-myc and v-ras oncogenes do not transform normal human lymphocytes.

Area of Science:

• Molecular Biology
• Oncogenesis
• Cellular Transformation

Background:

• Oncogenes play a critical role in cellular transformation and cancer development.
• Understanding the factors influencing oncogene expression and function in different cell types is crucial for cancer research.

Purpose of the Study:

• To investigate the transfer, stability, and expression of v-myc and v-Ha-ras oncogenes in various human cell types, including normal lymphocytes.
• To determine if co-expression of these oncogenes can induce cell growth and immortalization in human lymphocytes.

Main Methods:

• Gene transfer using a reconstituted Sendai virus envelope technique to introduce v-myc and v-Ha-ras oncogenes.
• Southern blotting to assess plasmid DNA stability in extrachromosomal DNA extracts.
• Detection of gene expression using molecular assays.
• Assessment of cellular DNA synthesis and immortalization potential.

Main Results:

• Efficient gene transfer was observed across all tested cell types (lymphocytes, fibroblasts, lymphoblastoid cells, epithelial cells).
• v-myc plasmid DNA showed instability in normal lymphocytes but was stabilized upon co-transfection with v-Ha-ras.
• v-myc expression was detected in most cell types, with co-transfection enabling expression in lymphocytes.
• Despite successful gene expression and stability, v-myc and v-Ha-ras co-transfection did not induce DNA synthesis or immortalization in human lymphocytes, unlike in NIH 3T3 fibroblasts.

Conclusions:

• Efficient expression of v-myc and v-Ha-ras oncogenes alone is insufficient to induce cell growth and immortalization in normal quiescent human lymphocytes.
• Lymphocytes possess intrinsic mechanisms that prevent transformation by these specific oncogenes, even when delivered effectively.